Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.320 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms 		0.310 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus 		0.310 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0005396
Disease: Bile Duct Neoplasms
Bile Duct Neoplasms 		0.300 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C0007140
Disease: Carcinosarcoma
Carcinosarcoma 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0007873
Disease: Uterine Cervical Neoplasm
Uterine Cervical Neoplasm 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0025500
Disease: Mesothelioma
Mesothelioma 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms 		0.300 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0205944
Disease: Sarcoma, Epithelioid
Sarcoma, Epithelioid 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0205945
Disease: Sarcoma, Spindle Cell
Sarcoma, Spindle Cell 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C0740277
Disease: Bile duct carcinoma
Bile duct carcinoma 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C1257931
Disease: Mammary Neoplasms, Human
Mammary Neoplasms, Human 		0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C1261473
Disease: Sarcoma
Sarcoma 		0.300 Biomarker group CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.300 Biomarker group CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C1708349
Disease: Hereditary Diffuse Gastric Cancer
Hereditary Diffuse Gastric Cancer 		0.300 Biomarker disease CTD_human Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. 29707199 2018
CUI: C4704874
Disease: Mammary Carcinoma, Human
Mammary Carcinoma, Human 		0.300 Biomarker disease CTD_human Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. 28690657 2017
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.030 Biomarker group BEFREE Therefore, lncRNA MORT may inhibit cancer cell proliferation in prostate carcinoma by preventing glucose uptake. 31516590 2019
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion 		0.030 Biomarker phenotype BEFREE However, overexpression of lncRNA MORT showed no significant effects on cancer cell migration and invasion. 30916806 2019
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion 		0.030 Biomarker phenotype BEFREE MiR-93-3p inhibition and ZNF667-AS1 elevation also inhibited cell cycle entry and cell invasion in vitro, but repressed tumor growth and metastasis in vivo. 31420931 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm 		0.030 Biomarker group BEFREE Therefore, lncRNA MORT may inhibit cancer cell proliferation in prostate carcinoma by preventing glucose uptake. 31516590 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.020 Biomarker phenotype BEFREE MiR-93-3p inhibition and ZNF667-AS1 elevation also inhibited cell cycle entry and cell invasion in vitro, but repressed tumor growth and metastasis in vivo. 31420931 2019
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis 		0.020 Biomarker phenotype BEFREE The epigenetic silencing of MORT in a large majority of the common human cancers suggests a potential fundamental role in cellular immortalization during human carcinogenesis. 26646903 2015